EP2383269
Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.10.2007EP published:
18.1.2017EP application number:
11175197.0
EPO information:
European Patent Register
Max expiry date:
11.10.2027
Title:
Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
Timeline
Today
12.10.2007EP application
18.1.2017EP Publication
Owner
Name:
Bayer Intellectual Property GmbHAddress:
Alfred-Nobel-Strasse 10, 40789, Monheim, DE
Inventor
Name:
Thede, KaiAddress:
Berlin, DE
Name:
Flamme, IngoAddress:
Reichshof, DE
Name:
Oehme, FelixAddress:
Wuppertal, DE
Name:
Ergüden, Jens-KerimAddress:
Wülfrath, DE
Name:
Stoll, FriederikeAddress:
Düsseldorf, DE
Name:
Schuhmacher, JoachimAddress:
Wuppertal, DE
Name:
Wild, HannoAddress:
Wuppertal, DE
Name:
Kolkhof, PeterAddress:
Wuppertal, DE
Name:
Beck, HartmutAddress:
Wuppertal, DE
Name:
Keldenich, JörgAddress:
Wuppertal, DE
Name:
Akbaba, MetinAddress:
Ratingen, DE
Name:
Jeske, MarioAddress:
Solingen, DE
Priority
Number:
102006050516Date:
26.10.2006Country:
DE
Classification
Categories:
C07D 401/14, C07D 403/14, C07D 413/14, C07D 417/14, A61K 31/41, A61K 31/435, A61K 31/495, A61P 7/00, A61P 9/00